Last reviewed · How we verify
NCT06097897
Imaging of Vitreous Opacities in Human Eyes
NA trial testing SVO-ID in Floaters in 91 participants. Completed in 18 March 2025.
18 March 2025
Quick facts
| Lead sponsor | PulseMedica |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 91 |
| Start date | 1 April 2024 |
| Primary completion | 18 March 2025 |
| Estimated completion | 18 March 2025 |
| Sites | 1 location across Panama |
Drugs / interventions tested
- SVO-ID
Conditions studied
- Floaters — all drugs for Floaters →
- Vitreous Opacities — all drugs for Vitreous Opacities →
Sponsor
PulseMedica
Who can join
18 and older, any sex, with Floaters or Vitreous Opacities. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Vitreous opacities (VOs), commonly known as floaters, are dark spots that appear in, and may float across your vision. Presently, there is a lack of available data in the literature regarding VOs. This study aims to obtain imaging data of VOs in the population to build an imaging database of VOs to learn more about them.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06097897
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of SVO-ID
Trials testing the same drug.
- NCT06204848 — Imaging of Vitreous Opacities in a Canadian Population · NA · completed
Other PulseMedica trials
Trials by the same sponsor.
- NCT06204848 — Imaging of Vitreous Opacities in a Canadian Population · NA · completed
- NCT05608265 — Real-time Eye Tracking and Imaging of the Eye in Diabetic Retinopathy Patients · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06097897 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by PulseMedica
- Last refreshed: 8 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06097897.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing